It does all relate together. Certainly not all genetic diseases are rare diseases; however, about 80% of the rare diseases are genetic diseases.
One of the biggest challenges, quite frankly, is being able to identify and diagnose a disease. As we often say to families, when you have a disease or you have a condition that's not diagnosed, it's not that it's not diagnosable; it's just that we haven't been able to diagnose it.
So having some means of being able to diagnose a disease, and diagnose it fairly accurately, can then actually lead to a whole host of either preventive actions or at least supportive actions. That's the first step.
We do need to have these national centres of reference where we can then actually refer patients in order for them to get ongoing kinds of support and intelligence. So it's the first step towards it. But you're absolutely right that if all we're doing is diagnosing the disease and we're not doing any of the other kinds of work necessary, we could actually be leaving a lot of families in a lot worse condition than if they didn't know.
So it is part and parcel of an overall strategy, but as we've said here already, we know it has to be national. We should not ask each province to do this. It makes no sense to do that.
I go back to saying that we would love to have the dialogue. The next step beyond an orphan drug regulatory framework is to really talk about a national strategy, and I think it's a public health strategy.